AzTrials
AzTrials

Buccal Infiltration Inferior Alveolar Nerve Block ArticaineNCT04294745

Comparing Buccal Infiltration and Inferior Alveolar Nerve Block for Extraction of Mandibular Teeth

A study testing Buccal infiltration and Inferior alveolar nerve block in people with Buccal Infiltration Inferior Alveolar Nerve Block Articaine, run by Melaka Manipal Medical College at 1 site in Malaysia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study compares the effectiveness of two techniques of local anesthesia in the extraction of mandibular teeth. One group received inferior alveolar nerve block and the other group received buccal infiltration of 4% Articaine Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
What is being tested?
Buccal infiltration and Inferior alveolar nerve block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteMalaysia
Study dates
1 Feb 2019to 30 Jan 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Mandibular teeth
  • grossly decayed teeth
  • root stumps
  • therapeutic extractions
  • American society of anesthesiologist classification I \& II patients

Who cannot join

  • patients allergic to local anesthesia
  • infected teeth
  • grade 2 and grade 3 mobile teeth
  • patients already taking medications which influences the anaesthetic assessment

Trial locations and contacts

1 site in 1 country.

Malaysia1 site
  • Melaka Manipal Medical College

    Malacca, 75150

Other trials in Malaysia

About this study

Official title: Effectiveness of Buccal Infiltration and Inferior Alveolar Nerve Block With Articaine for Extraction of Mandibular Teeth- A Randomized Clinical Trial

This study compares the effectiveness of two techniques of local anesthesia in the extraction of mandibular teeth. One group received inferior alveolar nerve block and the other group received buccal infiltration of 4% Articaine

Read the detailed description

Inferior alveolar nerve block is the commonly used local anesthetic injection technique for extraction of mandibular teeth. Buccal infiltration technique alone is considered to be ineffective in treating mandibular teeth due to the thickness of buccal cortical plate. However, buccal infiltration, if provided with an agent with higher penetration capability, may be used instead of Inferior alveolar nerve block. Articaine, due to its thiophene ring, has higher liposolubility and bony diffusion than any other agent.

This study compares the effectiveness of inferior alveolar nerve block and buccal infiltration using 4% Articaine in the extraction of mandibular teeth

Being tested
Buccal infiltration, Inferior alveolar nerve block
Keywords
Buccal infiltration inferior alveolar nerve block Articaine

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Buccal infiltrationProcedure or surgery

    Injection of local anaesthetic parallel to the Long axis of the tooth in the depth of buccal sulcus

  • Inferior alveolar nerve blockProcedure or surgery

    Standard technique of mandibular nerve block

Study groups in NCT04294745
Study groupRoleWhat they receive
Group AExperimentalBuccal infiltration of 4% Articaine
Receives: Procedure: Buccal infiltration
Group BActive comparatorInferior alveolar nerve block of 4% Articaine
Receives: Procedure: Inferior alveolar nerve block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain during injection using a visual analogue scale measuring 10 cm with 0 depicting no pain and 10 depicting severe pain

    VAS scale is a validated scale measuring pain with possible score range from 0 (no pain) to 10 (severe pain).

    Measured: During injection

  2. Pain during extraction using a visual analogue scale measuring 10 cm with 0 depicting no pain and 10 depicting severe pain

    VAS scale is a validated scale measuring pain with possible score range from 0 (no pain) to 10 (severe pain).

    Measured: During extraction

  3. Requirement of rescue injection

    whether a recue injection was given or not

    Measured: During extraction

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Mar 2020
  2. Study start1 Feb 2019
  3. Primary completion30 Jan 2020
  4. Study completion30 Jan 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04294745
Sponsor's protocol ID
MMMC/FOD/AR/B7/E C-2019 (04)
Status last verified
Sep 2023
First submitted
2 Mar 2020
Last updated
2 Oct 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Buccal infiltration and Inferior alveolar nerve block in people with Buccal Infiltration Inferior Alveolar Nerve Block Articaine, run by Melaka Manipal Medical College at 1 site in Malaysia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Malaysia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain during injection using a visual analogue scale measuring 10 cm with 0 depicting no pain and 10 depicting severe pain (time frame: During injection). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in